| Identification | More | [Name]
BOC-SAR-OH | [CAS]
13734-36-6 | [Synonyms]
BOC-MEGLY-OH
BOC-N-ALPHA-METHYLGLYCINE
BOC-N-ME-GLY-OH
BOC-N-METHYLGLYCINE
BOC-SAR
BOC-SARCOSINE
BOC-SAR-OH
N-ALPHA-T-BOC-N-ALPHA-METHYLGLYCINE
N-ALPHA-T-BOC-SARCOSINE
N-ALPHA-T-BUTOXYCARBONYL-N-ALPHA-METHYL-GLYCINE
N-ALPHA-T-BUTOXYCARBONYL SARCOSINE
N-BOC-N-METHYLGLYCINE
N-BOC-SARCOSINE
N-T-BOC-SARCOSIN
N-T-BUTOXYCARBONYL SARCOSINE
N-(TERT-BUTOXYCARBONYL)SARCOSINE
N-TERT-BUTYLOXYCARBONYL-N-METHYL-GLYCINE
N-TERT-BUTYLOXYCARBONYL-SARCOSINE
RARECHEM EM WB 0206
T-BUTYLOXYCARBONYLSARCOSINE | [EINECS(EC#)]
237-306-0 | [Molecular Formula]
C8H15NO4 | [MDL Number]
MFCD00037795 | [Molecular Weight]
189.21 | [MOL File]
13734-36-6.mol |
| Safety Data | Back Directory | [Safety Statements ]
S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [F ]
21 | [TSCA ]
Yes | [HazardClass ]
IRRITANT | [HS Code ]
29241990 |
| Hazard Information | Back Directory | [Chemical Properties]
white crystals or crystalline powder | [Uses]
Boc-N-methylglycine is used in the preparation of Clavatustide A (C563723) and Clavatustide B (C563725), which have been shown to suppress the proliferation of human hepatocellular carcinoma cells under specific conditions. | [reaction suitability]
reaction type: Boc solid-phase peptide synthesis |
|
|